https://european-biotechnology.net/wp-content/uploads/2024/07/GlaxoSmithKline_Headquarters_on_the_Great_West_Road_in_Brentford_-_panoramio-1030x684-1.png
684
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2025-07-30 09:28:132025-07-30 09:28:13GSK licenses COPD blockbuster in US$12bn deal
https://european-biotechnology.net/wp-content/uploads/2025/07/Alex-Blyth-CEO-and-founder-of-Lift-Biosiences-e1753779779660-1030x581-1.jpg
581
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2025-07-29 09:18:542025-07-29 09:18:54LIfT BioSciences Ltd receives €12m for clinical translation of IMANs
https://european-biotechnology.net/wp-content/uploads/2025/07/EU-trade-deal-e1753701914766.jpg
563
1000
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2025-07-28 11:25:342025-07-28 11:25:34Import tariff of 15%: significant implications for pharmaceutical firms
https://european-biotechnology.net/wp-content/uploads/2025/07/Bayer-Berlin_428625549_nMEd7NyJ7x7YYS941qTmpiKXLUeNZHgC-e1753694788880.jpg
563
1000
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2025-07-28 09:27:482025-07-28 09:27:48Bayer targets leading position in HER2-positive NSCLC
https://european-biotechnology.net/wp-content/uploads/2025/07/Curevac_2ndgen-1030x683-1.jpg
683
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2025-07-24 06:20:492025-07-24 06:20:49From Brisbane to London to Paris: Vicebio´s Sanofi deal
https://european-biotechnology.net/wp-content/uploads/2025/07/Bildschirmfoto_2022-09-02_um_10.45.28.png
167
334
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2025-07-23 13:52:012025-07-24 07:32:02Abivax soars 500% on TOP-Line data
https://european-biotechnology.net/wp-content/uploads/2025/07/AZ_headquarters-1030x605-1.jpg
605
1030
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2025-07-23 08:44:582025-07-23 08:44:58Westwards: AstraZeneca Shifts Gears with $50 Billion US Investment
https://european-biotechnology.net/wp-content/uploads/2025/07/Carbios-Production.png
565
843
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2025-07-22 09:10:552025-07-22 09:10:55Carbios is back with a partnership in the automotive tyre industry
https://european-biotechnology.net/wp-content/uploads/2025/07/EB-Winter-201__tumour_cell_123rf__Jovanche_Vitanovski_36161037_tg.jpg
619
774
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2025-07-21 14:07:192025-07-21 14:07:19One Bioscience raises €15m to leverage AI tumour profiling
https://european-biotechnology.net/wp-content/uploads/2025/07/RS2677_AdobeStock_42818981_lpr.jpg
540
960
Thomas Gabrielczyk
/wp-content/uploads/2019/12/ebn-1-300x135.png
Thomas Gabrielczyk2025-07-18 09:39:412025-07-18 09:39:41Bold UK-Strategy in Life Sciences
Scroll to top
